F.D.A. to Expand Scrutiny of Risks From Drugs After They’re Approved for Sale

Tuesday, May 27, 2008 - 13:35 in Health & Medicine

Repeated instances in which popular medicines proved deadly have prompted further monitoring of drugs already on the market.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net